20:29 19.04.26
Erstelle meine Watchlist und Depot login | Registrieren
Amgen Inc US0311621009

Amgen upgraded to "buy"

12.10.09 - UBS

NEW YORK, October 12 (newratings.com) - Analysts at UBS upgrade Amgen (AMGN) from "neutral" to "buy." The target price has been raised from $63 to $70.

                                                                                                                        

Verbessern Sie newratings! Was könnte newratings besser machen?